SEC Form D · Amendment · filed December 6, 2018
Genomind, Inc
Industry
Other Health Care
Location
King of Prussia, PA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Kip P. Olmstead · King of Prussia, PAExecBeth E. Dozoretz · Norfolk, VAExec · DirectorGloria E. Nuss · Norfolk, VAExecShawn P. O'Brien · King of Prussia, PAExec · DirectorRonald I. Dozoretz · Norfolk, VAExec · Director · PromoterJoseph E. Anton · Boston, MADirectorStephen E. Haller · Norfolk, VAExecJohn E. Chadwick · Nashville, TNDirectorThomas E. Hess · King of Prussia, PAExecTheresa E. Sexton · Nashville, TNDirectorPCM Capital Select Managers Fund LLC · Kansas City, MODirectorBarden Gale · New York, NYExecMichael Mcgillis · New York, NYExec · DirectorRail-Splitter Capital Management, LLC · Chicago, ILDirectorPhalanx Capital GP, LLC · Chicago, ILExec · DirectorHoward S. Silverman · OMAHA, NEExec · Director · PromoterRobert A. Dean · OMAHA, NEExec · DirectorDouglas L. Dethy · New York, NYExec · DirectorDouglas B. Dunn · Houston, TXExec · Director · PromoterPCM Capital Managed Equity Fund I LLC · Kansas City, MOExecAugusto Alvarez · Santa Fe, O5ExecDavid Riker · New York, NYDirectorJonathan Budd · DEL MAR, CAExecMitchell B. Kleinhandler · ATLANTA, GAExecDavid B. Citron · ATLANTA, GAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗